Liver Biopsy Shines a Light on COVID-19-Related Liver Injury.
作者信息
Kleiner David E
机构信息
Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland.
出版信息
Cell Mol Gastroenterol Hepatol. 2021;11(3):881-882. doi: 10.1016/j.jcmgh.2020.10.003. Epub 2020 Nov 2.
Abstract
摘要
相似文献
1
Liver Biopsy Shines a Light on COVID-19-Related Liver Injury.肝活检揭示新冠病毒相关肝损伤情况
Cell Mol Gastroenterol Hepatol. 2021;11(3):881-882. doi: 10.1016/j.jcmgh.2020.10.003. Epub 2020 Nov 2.
2
SARS-CoV-2 infection in patients with a normal or abnormal liver.肝脏正常或异常患者的新型冠状病毒2型感染
J Viral Hepat. 2021 Jan;28(1):4-11. doi: 10.1111/jvh.13440. Epub 2020 Dec 1.
3
Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.SARS-CoV-2 感染患者的直接或间接肝损伤。
Semin Liver Dis. 2020 Aug;40(3):321-330. doi: 10.1055/s-0040-1715108. Epub 2020 Sep 4.
4
ACE2: from protection of liver disease to propagation of COVID-19.ACE2：从保护肝脏疾病到传播 COVID-19。
Clin Sci (Lond). 2020 Dec 11;134(23):3137-3158. doi: 10.1042/CS20201268.
5
Genetic insight into COVID-19-related liver injury.对新型冠状病毒肺炎相关肝损伤的遗传学见解。
Liver Int. 2021 Jan;41(1):227-229. doi: 10.1111/liv.14708. Epub 2020 Nov 3.
6
COVID-19-associated liver injury (COVALI): role of hepatologists.新型冠状病毒肺炎相关肝损伤（COVALI）：肝病专家的作用
J Gastroenterol. 2021 Aug;56(8):786-787. doi: 10.1007/s00535-021-01809-9. Epub 2021 Jul 2.
7
COVID-19 and the liver: What do we know after six months of the pandemic?COVID-19 与肝脏：大流行六个月后我们了解多少？
Ann Hepatol. 2020 Nov-Dec;19(6):590-591. doi: 10.1016/j.aohep.2020.09.001. Epub 2020 Sep 18.
8
Pattern of liver function and clinical profile in COVID-19: A cross-sectional study of 91 patients.COVID-19 患者肝功能及临床特征分析：91 例患者的横断面研究。
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1951-1954. doi: 10.1016/j.dsx.2020.10.001. Epub 2020 Oct 6.
9
Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.新型冠状病毒肺炎患者肝损伤的发生率及其与临床结局的相关性：系统评价与荟萃分析。
Eur Rev Med Pharmacol Sci. 2020 Dec;24(24):13072-13088. doi: 10.26355/eurrev_202012_24215.
10
SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.SARS-CoV-2 感染肝脏直接导致 COVID-19 患者肝损伤。
J Hepatol. 2020 Oct;73(4):807-816. doi: 10.1016/j.jhep.2020.05.002. Epub 2020 May 11.
引用本文的文献
1
Assessing the consistency of FIB-4, APRI, and GPR in evaluating significant liver fibrosis and cirrhosis in COVID-19 patients with concurrent liver diseases.评估FIB-4、APRI和GPR在评估合并肝脏疾病的COVID-19患者显著肝纤维化和肝硬化中的一致性。
BMC Gastroenterol. 2025 Mar 20;25(1):191. doi: 10.1186/s12876-025-03770-w.
2
Insight into COVID-19 associated liver injury: Mechanisms, evaluation, and clinical implications.对新型冠状病毒肺炎相关肝损伤的见解：机制、评估及临床意义
Hepatol Forum. 2024 Jul 2;5(3):139-149. doi: 10.14744/hf.2023.2023.0025. eCollection 2024.
3
Impact and management of COVID-19 in liver transplant candidates and recipients.新型冠状病毒肺炎对肝移植候选者及受者的影响与管理
Ann Gastroenterol. 2023 Sep-Oct;36(5):477-489. doi: 10.20524/aog.2023.0815. Epub 2023 Jul 3.
4
Liver pathology in COVID-19 related death and leading role of autopsy in the pandemic.COVID-19 相关死亡的肝脏病理学和尸检在大流行中的主导作用。
World J Gastroenterol. 2023 Jan 7;29(1):200-220. doi: 10.3748/wjg.v29.i1.200.
5
A Retrospective Analysis of COVID-19-infected Patients with Acute Hepatitis who Develop Acute Liver Failure in a Safety Net Hospital.安全网医院中 COVID-19 感染合并急性肝炎后发生急性肝衰竭患者的回顾性分析。
BMJ Open Gastroenterol. 2021 Nov;8(1). doi: 10.1136/bmjgast-2021-000738.
6
Intriguing findings of liver fibrosis following COVID-19.新冠病毒感染后肝纤维化的有趣发现。
BMC Gastroenterol. 2021 Oct 11;21(1):370. doi: 10.1186/s12876-021-01939-7.
Zotero 插件